Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,971 | 231 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,675 | 85 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $690.50 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $517.22 | 26 | $0 (2024) |
| Janssen Biotech, Inc. | $345.14 | 14 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $260.19 | 10 | $0 (2024) |
| Ardelyx, Inc. | $248.20 | 8 | $0 (2024) |
| Medtronic, Inc. | $238.28 | 3 | $0 (2024) |
| Gilead Sciences, Inc. | $221.19 | 12 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2022) |
| PFIZER INC. | $124.85 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,211 | 107 | ABBVIE INC. ($560.92) |
| 2023 | $2,002 | 95 | ABBVIE INC. ($835.99) |
| 2022 | $758.97 | 29 | ABBVIE INC. ($277.87) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 12/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Immunology | ||||||
| 12/10/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.87 | General |
| 12/10/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.91 | General |
| Category: GI | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $11.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Gastroenterology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: Gastroenterology | ||||||
| 10/29/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Immunology | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $122.55 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/15/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/09/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: ONCOLOGY | ||||||
| 10/08/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Hepatology / Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 301 | 315 | $44,710 | $20,185 |
| 2022 | 2 | 50 | 50 | $9,440 | $4,543 |
| 2020 | 3 | 174 | 201 | $30,361 | $8,792 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 64 | 64 | $14,080 | $6,056 | 43.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 111 | $9,990 | $6,016 | 60.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 86 | 86 | $13,760 | $4,889 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 37 | $5,180 | $2,844 | 54.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 17 | 17 | $1,700 | $380.55 | 22.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $5,280 | $2,677 | 50.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $4,160 | $1,867 | 44.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 129 | 155 | $22,527 | $6,742 | 29.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 34 | 35 | $7,702 | $2,012 | 26.1% |
| 81002 | Urinalysis, manual test | Office | 2020 | 11 | 11 | $132.00 | $38.00 | 28.8% |
About Stephanie Stebelton
Stephanie Stebelton is a Nurse Practitioner healthcare provider based in Warren, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1114262458.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Stephanie Stebelton has received a total of $4,971 in payments from pharmaceutical and medical device companies, with $2,211 received in 2024. These payments were reported across 231 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,971).
As a Medicare-enrolled provider, Stebelton has provided services to 525 Medicare beneficiaries, totaling 566 services with total Medicare billing of $33,520. Data is available for 3 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Warren, OH
- Active Since 11/27/2012
- Last Updated 08/01/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1114262458
Products in Payments
- RINVOQ (Biological) $724.64
- SKYRIZI (Biological) $601.79
- ENTYVIO (Biological) $517.22
- TRULANCE (Drug) $352.99
- XIFAXAN (Drug) $322.53
- OCALIVA (Drug) $260.19
- STELARA (Biological) $257.11
- IBSRELA (Drug) $248.20
- TREMFYA (Drug) $213.03
- INTERSTIM (Device) $209.79
- LINZESS (Drug) $178.80
- VELSIPITY (Drug) $124.85
- Epclusa (Drug) $76.50
- ZENPEP (Drug) $71.13
- CREON (Drug) $67.91
- VEGZELMA (Biological) $57.98
- SUCRAID (Drug) $50.77
- MAVYRET (Drug) $46.38
- Linzess (Drug) $42.19
- CYLTEZO (Drug) $37.83
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Warren
Jennifer Meitzner, N.p.-C, N.P.-C
Nurse Practitioner — Payments: $10,253
Brittany Mazejko
Nurse Practitioner — Payments: $4,405
Alisha Johnson, N.p, N.P
Nurse Practitioner — Payments: $3,245
June Argel, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $3,100
Mr. Josef Kotermanski, Np-C, NP-C
Nurse Practitioner — Payments: $3,025
Alexander Cole-Selvaggio, Anp-Bc, ANP-BC
Nurse Practitioner — Payments: $2,598